ET
Enliven Therapeutics Inc.
🇺🇸XNAS.ELVNUnited StatesHealthcare
$49.29USDdown -4.02 (-7.54%)OpenDelayed6:51 PM
Price$49.29-4.02 (-7.54%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29337E1029
- CUSIP
- 29337E102
Company
- Employees
- 67
- Headquarters
- Boulder, United States
- CEO
- Mr. Richard A. Fair M.B.A.
Market
- Shares outstanding
- 73.3M
- Market cap
- $3.61B
Highlights
- Market cap
- $3.9B
- EPS LTM
- -$1.45calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -34.09calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$105.93M-5.7%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$67.04M+5.26%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.